ACCURAMED
ActiveSummary
ACCURAMED has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €21.5m and a net result of €4.4m. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 74% of 6,131 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Articles of association
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- One provision in the deed